This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Substance Use Disorder
Information about Substance Use Disorder: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Substance Use Disorder
Most recent studies have shown that Substance Use Disorder shares some biological mechanisms with antisocial-personality-disorder, anxiety-disorders, attention-deficit-hyperactivity-disorder, bipolar-disorder, cancer-patients-and-suicide-and-depression, conduct-disorder, depressive-disorder, major-depressive-disorder, mental-disorders, mood-disorders, personality-disorders, post-traumatic-stress-disorder, psychotic-disorders, schizophrenia, substance-related-disorders.
Among the many pathways, these few ones have gauged particular interests from scientists studying Substance Use Disorder, and have been seen in publications frequently: Aging, Cognition, Corticosterone Secretion, Cortisol Secretion, Developmental Process, Drinking Behavior, Eating Behavior, Lactation, Mating, Pathogenesis, Response To Alcohol, Response To Antidepressant, Response To Drug, Response To Stress, Secretion, Sensitization, Social Behavior, Translation, Transport
Quite a number of genes have been found to play important roles in Substance Use Disorder, such as ACTG1, AKR1C2, ATP2A2, ATP6V0A1, CD4, COMT, COX5A, DRD2, EP300, FGF9, GAD1, MITF, NDUFB6, OPN1SW, RFC1, RFC2, RFC4, SERPINA3, SLC17A5, SLC6A4. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.